(CercleFinance.com) – Valbiotis announces the launch of a capital increase with elimination of preferential subscription rights and implementation of a priority period for the benefit of current shareholders
in the amount of €15 million through the issue of 3,363,229 New Shares at a unit price of €4.46.
This price represents a facial discount of 20.1% compared to the closing price of December 8, 2023 (5.58 E), and a discount of 16.5% compared to the weighted average of the volumes of the 5 preceding trading sessions. the setting of the price of the issue by the Management Board (5.34 E).
“The company is launching a capital increase which aims to ensure its growth and enable the self-financing of its growth, while maintaining the focus on its current activities,” commented Sébastien Peltier, chairman of the management board and co-founder of Valbiotis. .
‘Valbiotis hopes to attract the support of a wide range of investors and aims to become a major European player in 100% plant-based food supplements,’ he added.
The stock lost nearly 14% this morning, the biggest drop on the Paris market.